Lymph Node Growth Rate in Testicular Germ Cell Tumours: Implications for Computed Tomography Surveillance Frequency

被引:2
|
作者
Mazrani, W. [2 ]
O'Malley, M. E. [1 ,2 ]
Chung, P. W. M. [1 ]
Warde, P. [1 ]
Vesprini, D. [3 ]
Panzarella, T. [4 ,5 ]
机构
[1] Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Joint Dept Med Imaging, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Sunnybrook Odette Canc Ctr, Dept Radiat Oncol, Toronto, ON M5S 1A1, Canada
[4] Princess Margaret Hosp, Canc Program, Dept Biostat, Toronto, ON M5G 2M9, Canada
[5] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada
关键词
Computed tomography; growth rate; lymph node; surveillance; testicular cancer; TESTIS CANCER; SEMINOMA; GUIDELINES; MANAGEMENT; RELAPSE;
D O I
10.1016/j.clon.2010.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To estimate the growth rate of lymph nodes in patients on surveillance for testicular cancer who developed recurrent disease. Materials and methods: During a 7-year period, 318 patients at our institution were managed by surveillance and 39 relapsed (12.3%). The computed tomography scans of 28 patients (median age 32 years; range 19-51 years) who met our inclusion criteria and who developed recurrent disease in the abdomen/pelvis were retrospectively reviewed. Thirteen patients had non-seminoma and 15 had seminoma. To estimate the lymph node growth rate, the slope of lymph node size over time was calculated. Results: The median length of time from orchiectomy to the recurrence computed tomography was 131 days (range 49-520) or about 4.4 months for non-seminoma patients and 373 days (range 129-675) or about 12.3 months for seminoma patients. The median size of the involved lymph node at final computed tomography for seminoma patients was 12 mm (range 9-31 mm) and for non-seminoma patients was 15 mm (range 10-56 mm). The median lymph node growth rate for patients with seminoma was 1.35 mm/month (range 0.62-4.56) and for patients with non-seminoma 2.99 mm/month (range 0.77-7.06); the difference in growth rates was statistically significant (P = 0.029). Conclusions: There is a statistically significant faster growth rate of lymph nodes in patients with recurrent non-seminoma compared with patients with seminoma. This finding supports a more frequent computed tomography schedule during the first 2 years of surveillance in non-seminoma patients compared with seminoma patients. (C) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 50 条
  • [1] Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell Tumours
    Chung, Peter
    O'Malley, Martin E.
    Jewett, Michael A. S.
    Bedard, Philippe L.
    Panzarella, Tony
    Sturgeon, Jeremy
    Moore, Malcolm J.
    Hamilton, Robert
    Hansen, Aaron R.
    Anson-Cartwright, Lynn
    Gospodarowicz, Mary
    Warde, Padraig
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (04): : 437 - 442
  • [2] Retroperitoneal lymph node dissection for metastatic germ cell tumours
    Haldipur, N.
    Devaraj, S.
    Shehata, A.
    Lewis, A. K.
    Smith, M. O.
    Hatton, M.
    Nassef, A.
    Beard, J. D.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2011, 93 (04) : 301 - 305
  • [3] Predictive models for lymph node metastases in patients with testicular germ cell tumors
    Mao, Yun
    Hedgire, Sandeep
    Prapruttam, Duangkamon
    Harisinghani, Mukesh
    ABDOMINAL IMAGING, 2015, 40 (08): : 3196 - 3205
  • [4] Retroperitoneal lymph node dissection in testicular germ cell tumours: indications, complications and special cases
    John, Patricia
    Albers, Peter
    Hiester, Andreas
    Heidenreich, Axel
    AKTUELLE UROLOGIE, 2020, 51 (05) : 475 - 481
  • [5] Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era
    Yuasa, Takeshi
    Inoshita, Naoko
    Tanaka, Hajime
    Urakami, Shinji
    Yamamoto, Shinya
    Fujii, Yasuhisa
    Masuda, Hitoshi
    Fukui, Iwao
    Ishikawa, Yuichi
    Yonese, Junji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (06) : 1198 - 1202
  • [6] miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-up
    Chavarriaga, Julian
    Hamilton, Robert J.
    ANDROLOGY, 2023, 11 (04) : 628 - 633
  • [7] Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis
    Heidenreich, Axel
    Thuer, David
    Polyakov, Sergej
    EUROPEAN UROLOGY, 2008, 53 (02) : 260 - 274
  • [8] Predictive models for lymph node metastases in patients with testicular germ cell tumors
    Yun Mao
    Sandeep Hedgire
    Duangkamon Prapruttam
    Mukesh Harisinghani
    Abdominal Imaging, 2015, 40 : 3196 - 3205
  • [9] Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer
    Pearce, Shane M.
    Golan, Shay
    Gorin, Michael A.
    Luckenbaugh, Amy N.
    Williams, Stephen B.
    Ward, John F.
    Montgomery, Jeffrey S.
    Hafez, Khaled S.
    Weizer, Alon Z.
    Pierorazio, Phillip M.
    Allaf, Mohamad E.
    Eggener, Scott E.
    EUROPEAN UROLOGY, 2017, 71 (03) : 476 - 482
  • [10] Compliance of males with stage 1 testicular germ cell tumours on an active surveillance protocol
    Honeyball, F.
    Murali-Ganesh, R.
    Hruby, G.
    Grimison, P.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (10) : 1081 - 1084